View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
March 22, 2022

ProTrials selects Calyx as partner to boost trial outcomes data

Calyx provides rapid insights and aids in bringing new therapies for patients to market.

Clinical research organisation (CRO) ProTrials Research has selected eClinical and regulatory solutions and services provider Calyx as the approved partner to boost clinical trial outcomes data.

Through the collaboration, Calyx will expand its established interactive response technology (IRT), medical imaging, electronic data capture (EDC) solutions and services to aid global clients of ProTrials attain clinical development goals. 

Clients of ProTrials will use the new technology of Calyx to enhance the clinical trial outcomes data. This eventually enables them to offer safe medical therapeutics to patients.

ProTrials focuses on offering clinical operations services to the pharmaceutical, biotechnology and medical device sectors.

The company provides trial management, grant services, investigative site monitoring and linked clinical development services, among others.

ProTrials Research Quality Assurance director Christy Meyer said: “We’re pleased to partner with Calyx and are confident that our customers will benefit from the scientific, medical, and clinical expertise they have honed during their 30 years of delivering reliable eClinical solutions to the clinical development industry.”

Calyx has clinical development expertise and supports trial sponsors and CROs. 

Leveraging intelligence and expertise in solving complicated problems, Calyx provides rapid insights and aids in bringing new therapies to market.

Calyx Technical Solutions vice-president Elizabeth Dalton said: “We look forward to delivering the important imaging and eClinical data ProTrials’ customers rely on as they evaluate the safety and efficacy of often life-saving medical treatments. 

“We’re honoured that ProTrials selected Calyx to support them as they deliver on their commitment to improve the health and extend the lives of patients worldwide.”

Related Companies

Free Whitepaper
img

Unlocking the clinical trial potential of Africa

Ongoing improvements around infrastructure, continued investment, and being home to one of the world’s largest working age populations, means that Africa’s role in the clinical trials market has transformed. In this whitepaper, Oximio outlines the dynamics of today’s clinical trial market in Africa, including the key challenges the region is facing and how sponsors can overcome them to unlock the continent’s growing potential.
by Oximio
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU